283 related articles for article (PubMed ID: 3293079)
1. Immunological intervention in endotoxin shock.
Ziegler EJ
Prog Clin Biol Res; 1988; 272():319-25. PubMed ID: 3293079
[No Abstract] [Full Text] [Related]
2. Monoclonal antibodies and the treatment of gram-negative bacteremia and shock.
Wolff SM
N Engl J Med; 1991 Feb; 324(7):486-8. PubMed ID: 1988835
[No Abstract] [Full Text] [Related]
3. Lipopolysaccharide (LPS) from the cellular wall of Gram-negative bacteria, also known as endotoxin, is a key molecule in the pathogenesis of sepsis and septic shock. Preface.
Ronco C
Blood Purif; 2014; 37 Suppl 1():1. PubMed ID: 24457486
[No Abstract] [Full Text] [Related]
4. Clinical studies of monoclonal anti-lipid A antibody XMMEN-0E5.
Harkonen S; Kennedy D; Greenberg R
Prog Clin Biol Res; 1988; 272():395-406. PubMed ID: 3293083
[No Abstract] [Full Text] [Related]
5. Changes in anti-endotoxin-IgG antibody and endotoxaemia in three cases of gram-negative septic shock.
Barclay GR; Scott BB; Wright IH; Rogers PN; Smith DG; Poxton IR
Circ Shock; 1989 Oct; 29(2):93-106. PubMed ID: 2582583
[TBL] [Abstract][Full Text] [Related]
6. Bacteraemic and endotoxic shock.
Wardle N
Br J Hosp Med; 1979 Jul; 22(1):104. PubMed ID: 476340
[No Abstract] [Full Text] [Related]
7. The role of monoclonal antibodies in the management of gram-negative sepsis. Experience with the E5 antibody.
Gorelick KJ; Chmel H
Infect Dis Clin North Am; 1991 Dec; 5(4):899-913. PubMed ID: 1783775
[TBL] [Abstract][Full Text] [Related]
8. Antiendotoxin therapies for septic shock.
Corriveau CC; Danner RL
Infect Agents Dis; 1993 Feb; 2(1):44-52. PubMed ID: 8162353
[TBL] [Abstract][Full Text] [Related]
9. Production, characterization and biological effects of monoclonal antibodies to different parts of the gram-negative lipopolysaccharide core region.
Appelmelk BJ; Verweij-van Vught M; Brade H; Maaskant J; Schouten W; Thijs B; MacLaren D
Prog Clin Biol Res; 1988; 272():373-82. PubMed ID: 2455918
[No Abstract] [Full Text] [Related]
10. Recent developments in our understanding of sepsis: evaluation of anti-endotoxin antibodies and biological response modifiers.
Talan DA
Ann Emerg Med; 1993 Dec; 22(12):1871-90. PubMed ID: 8239111
[TBL] [Abstract][Full Text] [Related]
11. Antibodies to lipopolysaccharides: some diagnostic and protective aspects.
Fomsgaard A
APMIS Suppl; 1990; 18():1-38. PubMed ID: 2122911
[No Abstract] [Full Text] [Related]
12. Therapy of gram-negative sepsis in man with anti-endotoxin antibodies: a review.
Wortel CH; Ziegler EJ; van Deventer SJ
Prog Clin Biol Res; 1991; 367():161-78. PubMed ID: 1924425
[No Abstract] [Full Text] [Related]
13. Immunization with antibodies that mimic LPS protects against gram negative bacterial sepsis.
Klaerner HG; Dahlberg PS; Acton RD; Battafarano RJ; Uknis ME; Johnston JW; Dunn DL
J Surg Res; 1997 May; 69(2):249-54. PubMed ID: 9224390
[TBL] [Abstract][Full Text] [Related]
14. Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli.
Ziegler EJ; McCutchan JA; Fierer J; Glauser MP; Sadoff JC; Douglas H; Braude AI
N Engl J Med; 1982 Nov; 307(20):1225-30. PubMed ID: 6752708
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of type-specific and cross-reactive murine monoclonal antibodies directed against endotoxin during experimental sepsis.
Dunn DL; Bogard WC; Cerra FB
Surgery; 1985 Aug; 98(2):283-90. PubMed ID: 3895540
[TBL] [Abstract][Full Text] [Related]
16. Treatment of gram-negative bacteremia with antiserum to core glycolipid. I. The experimental basis of immunity to endotoxin.
Ziegler EJ; McCutchan JA; Braude AI
Eur J Cancer (1965); 1979; 15 Suppl():71-6. PubMed ID: 397063
[No Abstract] [Full Text] [Related]
17. Possibilities of immunoprophylaxis and immunotherapy in gut-derived infectious-toxic shock (GITS).
Imbach P; Hässig A; Cottier H
Curr Stud Hematol Blood Transfus; 1992; (59):301-23. PubMed ID: 1572217
[No Abstract] [Full Text] [Related]
18. Immunotherapy of sepsis.
Evans TJ; Cohen J
J Med Microbiol; 1993 Apr; 38(4):237-9. PubMed ID: 8474114
[No Abstract] [Full Text] [Related]
19. [Generation and characterization of avian vitelline antibodies against lipopolysaccharide and lipid A. 2. Investigations of specificity of egg yolk antibodies (IgY) against endotoxin].
Sasse M; Hlinak A
Berl Munch Tierarztl Wochenschr; 1998 Apr; 111(4):127-33. PubMed ID: 9581346
[TBL] [Abstract][Full Text] [Related]
20. Gram-negative bacteraemia: new therapeutic possibilities with anti-endotoxin antibodies.
Gaffin SL
Haematol Blood Transfus; 1985; 29():107-11. PubMed ID: 3896966
[No Abstract] [Full Text] [Related]
[Next] [New Search]
